In recent years, “sustainable investing”— meaning investment strategies that incorporate environmental, social, and governance (ESG) factors alongside traditional financial analysis — has grown considerably in attention and assets under management (AUM). According to a 2018 study, more than $12 trillion in assets in the U.S. alone were managed in a sustainable process, compared to $639 billion in 19951. We believe this trend will continue and that ESG ETFs will be a significant driver of this growth due to the structural efficiencies’ ETFs provide and the consistently expanding menu of exposure options.
The partnership with IndexIQ and CANDRIAM currently offers two ESG ETF Solutions (Tickers: IQSU and IQSI) and are in the process of bringing several “impact” funds to market.
1. Source: “The Forum for Sustainable and Responsible Investment (US SIF),” Trends Report 2018.
OXIO is the parent company of an initial group of five (5) innovative and relational companies that are poised to enter the market in Q4 2020 to address a number of systemic healthcare problems which are now reaching a breaking point due to the COVID-19 crisis. Healthcare is both the largest industry in the USA and the most complex with healthcare costs forecast to nearly double to more than US$6 trillion in the coming decade.
What you will hear in this webinar:
The substantial ROI opportunities, unseen by the typical investor, that exist in direct patient care, technology, IoT and in physical real estate used exclusively in healthcare that OXIO is multiplying through its unique investment vehicle it calls Distributive Venture Platform or DVP
How this addressable market of nearly $400 B in healthcare in these segments has limited competition and how OXIO is poised make an impact in a short period of time
How a skilled and experienced management team is bringing all these areas under one roof to capitalize on the tremendous economies of scale this creates as well as leveraging its robust IP that could change healthcare permanently
How can anyone ignore an opportunity where public companies are selling for 10-30X revenues and companies filing IPOs see share prices double on opening day?
You are invited to listen to OXIO’s top industry healthcare experts, visionaries and thought leaders talk about a new type of enterprise that brings technology to the care of patients, including the Medicare population that is growing at a rate of 10,000 persons a day. The team has also developed an innovative capital structure that will allow quick monetization as the company expands. OXIO combines the features of an incubator/accelerator and behaves more like venture capital, thus approaching private equity that it calls a Distributive Venture Platform™. This is a must hear presentation.
